200670 — Humedix Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapHigh Flyer

Annual income statement for Humedix Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	98,481	110,992	123,173	152,274	161,873
Cost of Revenue
Gross Profit	39,474	44,166	54,643	70,354	75,004
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	81,901	97,164	89,325	114,964	118,732
Operating Profit	16,579	13,828	33,848	37,310	43,141
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	20,309	11,339	28,989	32,410	48,355
Provision for Income Taxes
Net Income After Taxes	17,215	10,051	21,154	24,821	39,259
Minority Interest
Net Income Before Extraordinary Items
Net Income	15,084	9,065	21,086	24,821	39,259
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	15,084	9,065	21,086	24,821	39,259
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1,544	1,166	1,691	2,509	3,785
Dividends per Share